EP3411021
NÝ NOTKUN Á SAMSETNINGU SACUBITRIL OG VALSARTAN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.2.2017EP published:
14.5.2025EP application number:
17703477.4
EP translation filed:
1.8.2025Grant published:
15.9.2025EPO information:
European Patent Register
Max expiry date:
1.2.2037Expiry date:
1.2.2027Next due date:
28.2.2027
Title in English:
NEW USE OF A COMBINATION OF SACUBITRIL AND VALSARTANLanguage of the patent:
English
Timeline
Today
2.2.2017EP application
14.5.2025EP Publication
1.8.2025Translation submitted
15.9.2025Registration published
1.2.2027Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Inventor
Name:
CHEN, FabianAddress:
East Hanover, New Jersey 07936, US
Name:
AYALASOMAYAJULA, Surya PrakashAddress:
East Hanover, New Jersey 07936, US
Name:
BUSH, ChristopherAddress:
East Hanover, New Jersey 07936, US
Name:
BERKHIN, MashaAddress:
East Hanover, New Jersey 07936, US
Name:
WINZENBURG, GesineAddress:
4002 Basel, CH
Name:
TRUEBY, BerndAddress:
4002 Basel, CH
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
16154153Date:
3.2.2016Country:
EP
Number:
201662293005 PDate:
9.2.2016Country:
US
Number:
201662393163 PDate:
12.9.2016Country:
US
Classification
Categories:
A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/216, A61K 31/225, A61K 31/41, A61K 45/06, A61P 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 16.2.2026
Expires: 1.2.2027
Payer: Árnason Faktor ehf.